The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Mazzo David J since 2006.
The trader's CIK number is 1334549.
At the time of the last reporting, Mazzo David J was the Director of Eyepoint Pharmaceuticals, Inc.. (stock ticker symbol EYPT).
Also see all insider trading activities at Eyepoint Pharmaceuticals, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2006 | AVN | 1,000 | $15,590 | 0 | $0 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2019 | EYPT | 0 | $0 | 0 | $0 | 62,083 | $100,399 |
2018 | EYPT | 0 | $0 | 0 | $0 | 137,500 | $135,600 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2015 | CLBS | 20,000 | $27,919 | 0 | $0 | 0 | $0 |
1. Avanir Pharmaceuticals (AVN)
2. Eyepoint Pharmaceuticals, Inc. (EYPT)
3. Phase Iii Medical Inc/de (CLBS)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2006-02-14 | AVN | Buy | 1,000 | 15.59 | 15,590 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2019-10-09 | EYPT | Option Ex | 33,333 | 1.95 | 64,999 |
2019-09-06 | EYPT | Option Ex | 417 | .00 | 0 |
2019-06-21 | EYPT | Option Ex | 8,333 | .00 | 0 |
2019-03-29 | EYPT | Option Ex | 20,000 | 1.77 | 35,400 |
2018-06-27 | EYPT | Option Ex | 17,500 | .00 | 0 |
2018-04-20 | EYPT | Option Ex | 120,000 | 1.13 | 135,600 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2015-08-17 | CLBS | Buy | 20,000 | 1.40 | 27,919 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mazzo David J (Director of Eyepoint Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.